PATENT CLAIM ANALYSIS

Application Number: 15766667
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "300000"]

Abstract:
The present disclosure is directed to disclosed compounds that modulate, e.g., address underlying defects in cellular processing of CFTR activity.

Claim (Index 12):
The compound of  claim 11 , wherein R gg  is selected from the group consisting of: halogen, hydroxyl, C 1-6 alkoxy, C 3-6 cycloalkyl (optionally substituted by one or two substituents independently selected from the group consisting of hydroxyl, C 1-3 alkyl and C 1-3 alkoxy), phenyl, wherein R 11 , R 22 , R 33  and R 44  are independently selected for each occurrence from the group consisting of hydrogen, hydroxyl, C 1-6 alkyl, C 1-3 alkoxy and oxo; and wherein R N  is selected from the group consisting of hydrogen and \u2014S(O) 2 \u2014C 1-3 alkyl; and wherein phenyl may be optionally substituted by on one two substituents selected from R hh .

Metadata:
- Claim Count in Document: 140.0
- Percentile: 91.0
- Lexical Diversity: 1.04545
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15747290', '15539392', '16091401', '15539397', '15320172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.834357766136124
- 35 USC 102 Novelty (BERT): 0.5324505890095662
- Combined Prediction Score: 0.8041670484234683
- Mean Citation Score: 357.125496
- Max Citation Score: 371.4623
- Similarity Product: 322.0098509349823

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test